X Close

This hyperlink will direct you to a non-governmental Website or application.

The appearance of external hyperlinks does not constitute endorsement by the United States Department of Health & Human Services (HHS) of the hyperlinked Website or application, or the information, products or services contained therein. Such hyperlinks are provided consistent with the intended purpose of this HHS Website. Visitors to the hyperlinked Website or application will be subject to the Website or application's privacy policies. These practices may be different than those of this HHS Website.

You will be redirected to: link

We Support a Healthier Future - Healthy People 2020

Office of Orphan Products Development, U.S. Food and Drug Administration - OOPD/FDA

Organization URL(s)

www.fda.gov/orphan/index.htm

Other Contact Information

WO32-5271
10903 New Hampshire Avenue
Silver Spring, MD 20993-0002

800-300-7469 (Voice - Toll-free)
301-796-8660 (Voice)
301-847-8621 (FAX)

Description

The FDA's Office of Orphan Products Development (OOPD) is dedicated to promoting the development of products that demonstrate promise for the diagnosis and/or treatment of rare diseases or conditions. To locate such products, the OOPD interacts with the medical and research communities, professional organizations, academia, and the pharmaceutical industry, as well as rare disease groups. The OOPD administers the major provisions of the Orphan Drug Act (ODA) which provide incentives for sponsors to develop products for rare diseases. More than 228 drugs and biological products for rare diseases have been brought to market since 1983.

Office of Orphan Products Development, U.S. Food and Drug Administration - OOPD/FDA

Organization URL(s)

Other Contact Information

Description

Related Topics

Review Date